Persistent ebola virus in the eye: The authors reply

New England Journal of Medicine

Volumn 373, Issue 20, 2015, Pages 1982-1983

  Yeh, Steven ^a   Varkey, Jay B ^a   Crozier, Ian ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

FAVIPIRAVIR; GLUCOCORTICOID;

CD8+ T LYMPHOCYTE; CYTOPATHOGENIC EFFECT; EBOLAVIRUS; HUMAN; LETTER; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SURVIVOR; UVEITIS; VIRAL EYE INFECTION; VIRUS REPLICATION; AQUEOUS HUMOR; COMPLICATION; EBOLA HEMORRHAGIC FEVER; ISOLATION AND PURIFICATION; MALE; VIROLOGY; VISUAL DISORDER;

AQUEOUS HUMOR; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; MALE; PANUVEITIS; VISION DISORDERS;

EID: 84946781922     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1510459     Document Type: Letter

References (2)

1. McElroy AK, Akondy RS, Davis CW, et al. Human Ebola virus infection results in substantial immune activation. Proc Natl Acad Sci U S A 2015;112:4719-24.
2. Shantha JG, Weissman HM, Debiec MR, Albini TA, Yeh S. Advances in the management of acute retinal necrosis. Int Ophthalmol Clin 2015;55:1-13.